
Anixa Biosciences ANIX
$ 3.12
-1.89%
Quarterly report 2025-Q2
added 09-10-2025
Anixa Biosciences P/B Ratio 2011-2025 | ANIX
Annual P/B Ratio Anixa Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00375 | 0.00646 | 0.00487 | 1.73 | 7.1 | 15.7 | 13.3 | 3.85 | 55.4 | 5.35 | 10.1 | -13.7 | -33.4 | 22.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.4 | -33.4 | 6.29 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
3.17 | $ 18.98 | -0.32 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
1.22 | $ 20.62 | 0.26 % | $ 222 M | ||
|
Co-Diagnostics
CODX
|
0.406 | $ 0.18 | -21.16 % | $ 5.28 M | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 39.31 | 0.1 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
1.96 | $ 230.67 | 0.02 % | $ 169 B | ||
|
DarioHealth Corp.
DRIO
|
0.45 | $ 10.7 | 2.0 % | $ 304 M | ||
|
BioNano Genomics
BNGO
|
0.1 | $ 1.5 | 0.67 % | $ 1.91 M | ||
|
Exact Sciences Corporation
EXAS
|
3.88 | $ 101.9 | -0.03 % | $ 18.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
23.6 | $ 67.06 | -0.61 % | $ 25.9 B | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 26.49 | -0.41 % | $ 801 M | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
1.99 | $ 19.07 | -0.68 % | $ 1.03 B | ||
|
Celcuity
CELC
|
3.45 | $ 99.92 | -1.61 % | $ 3.94 B | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
5.88 | $ 227.69 | 0.26 % | $ 41.3 B | ||
|
Guardant Health
GH
|
-41.8 | $ 100.6 | -0.78 % | $ 12.3 B | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
1.39 | $ 6.17 | -2.22 % | $ 559 M | ||
|
ENDRA Life Sciences
NDRA
|
0.86 | $ 4.76 | -1.24 % | $ 2.56 M | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 7.05 | -2.35 % | $ 1.53 B | ||
|
Koninklijke Philips N.V.
PHG
|
0.995 | $ 27.39 | 0.48 % | $ 20 B | ||
|
Personalis
PSNL
|
1.25 | $ 7.97 | 0.5 % | $ 472 M | ||
|
Quidel Corporation
QDEL
|
7.93 | $ 29.3 | - | $ 1.23 B | ||
|
National Research Corporation
NRC
|
20.6 | $ 18.65 | -1.69 % | $ 458 M | ||
|
RadNet
RDNT
|
3.25 | $ 71.49 | -1.81 % | $ 5.22 B | ||
|
Illumina
ILMN
|
2.6 | $ 132.75 | -1.29 % | $ 21.1 B | ||
|
Charles River Laboratories International
CRL
|
2.44 | $ 201.98 | -0.58 % | $ 10.4 B | ||
|
Soleno Therapeutics
SLNO
|
7.98 | $ 46.29 | -2.65 % | $ 1.86 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.18 | $ 175.49 | -0.02 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
4.41 | $ 6.72 | -2.04 % | $ 871 M | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
2.62 | $ 253.07 | 0.04 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 183.0 | 0.35 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
23.6 | $ 682.32 | -0.81 % | $ 56.3 B | ||
|
Lantheus Holdings
LNTH
|
5.94 | $ 67.16 | -0.27 % | $ 4.65 B | ||
|
Mettler-Toledo International
MTD
|
-236 | $ 1 414.32 | -0.36 % | $ 30 B |